Former U.S. President Joe Biden, 82, has been diagnosed with an aggressive form of prostate cancer, according to a statement released by his personal office on May 18, 2025. The diagnosis followed medical evaluations prompted by increasing urinary symptoms and the discovery of a prostate nodule.
On May 16, Biden was diagnosed with Grade Group 5 prostate cancer, characterized by a Gleason score of 9 and metastasis to the bone. Despite the severity, the cancer is hormone-sensitive, which allows for effective management. Biden and his family are currently reviewing treatment options with his physicians.
In an emotional statement shared on social media, Biden expressed gratitude for the public’s support, stating, “Cancer touches us all. Like so many of you, Jill and I have learned that we are strongest in the broken places. Thank you for lifting us up with love and support.”
The news has prompted an outpouring of support from political figures across the spectrum. Former President Donald Trump extended his best wishes for a speedy recovery, and Vice President Kamala Harris emphasized Biden’s resilience and expressed hope for a full recovery.
Prostate cancer is one of the most common cancers among men in the U.S., and while the overall five-year survival rate is high, it decreases significantly when the cancer has spread to other parts of the body. Advances in treatment offer hope, and patients with metastatic prostate cancer can expect to live several years with appropriate therapy.
Biden’s diagnosis marks a significant shift in his health status, as previous routine physical exams had indicated no major concerns. The former president and his medical team are now focused on determining the best course of treatment moving forward.